Citations

Showing 10 of 108119 citations.

The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study
Morales‐Arráez, Dalia , Ventura‐Cots, Meritxell , Altamirano, José , Abraldeṣ, Juan G. , Cruz‐Lemini, M. , Thursz, Mark , Chavez-Araujo, Roberta, Tijera, Fatima Higuera‐de la , Shah, Vijay H. , Kamath, Patrick S. , Duarte‐Rojo, Andrés , Charles, Emmanuelle, Vargas, Vı́ctor , Jäger, Marion , Rautou, Pierre‐Emmanuel , Zamarripa, Felipe , Restrepo-Gutiérrez, J.C., Torre, Aldo , Lucey, Michael R. , Mathurin, P., García–Tsao, Guadalupe , Verna, Elizabeth C. , Argemí, Josepmaria , Fernández‐Carrillo, Carlos , Clemente, Ana , Alvarado‐Tápias, Edilmar , Forrest, Ewan , Mathurin, Philippe , Duarte-Rojo, Andres , Vargas, Victor , Ventura Cots, Meritxell , Abraldes, Juan G , Rautou, Pierre-Emmanuel , Atkinson, Stephen R. , Sarin, Shiv Kumar , Kim, Won Kyum , Singal, Ashwani K. , Rincón, Diego , Arab, Juan Pablo , Louvet, Alexandre , González, José Alberto , Brown, Robert S. , Allison, Michael , Bataller, Ramon A

Mayo Clinic

American Journal of Gastroenterology | December 28, 2021 | Volume: 117 | Issue: 2 | Pages: 301-310

10.14309/ajg.0000000000001596 | PMID 34962498 Get It

INTRODUCTION: Several scoring systems predict mortality in alcohol-associated hepatitis (AH), including the Maddrey discriminant function (mDF) and model for end-stage liver disease (MELD) score developed in the United States, Glasgow alcoholic hepatitis score in the United Kingdom, and age, bilirubin, international normalized ratio, and creatinine score in Spain. To date, no global studies have examined the utility of these scores, nor has the MELD-sodium been evaluated for outcome prediction in AH. In this study, we assessed the accuracy of different scores to predict short-term mortality in AH and investigated additional factors to improve mortality prediction. METHODS: Patients admitted to hospital with a definite or probable AH were recruited by 85 tertiary centers in 11 countries and across 3 continents. Baseline demographic and laboratory variables were obtained. The primary outcome was all-cause mortality at 28 and 90 days. RESULTS: In total, 3,101 patients were eligible for inclusion. After exclusions (n = 520), 2,581 patients were enrolled (74.4% male, median age 48 years, interquartile range 40.9–55.0 years). The median MELD score was 23.5 (interquartile range 20.5–27.8). Mortality at 28 and 90 days was 20% and 30.9%, respectively. The area under the receiver operating characteristic curve for 28-day mortality ranged from 0.776 for MELD-sodium to 0.701 for mDF, and for 90-day mortality, it ranged from 0.773 for MELD to 0.709 for mDF. The area under the receiver operating characteristic curve for mDF to predict death was significantly lower than all other scores. Age added to MELD obtained only a small improvement of AUC. DISCUSSION: These results suggest that the mDF score should no longer be used to assess AH's prognosis. The MELD score has the best performance in predicting short-term mortality.
Role of Echocardiography for Assessment of Cardiac Remodeling in Congenitally Corrected Transposition of Great Arteries
Egbe, Alexander C. , Miranda, William R. , Connolly, Heidi M.

Mayo Clinic

Circulation: Cardiovascular Imaging | December 28, 2021 | Volume: 15 | Issue: 1 | Pages: No page available

10.1161/circimaging.121.013477 | PMID 34961324 Get It

Background: The purpose of this study was to assess the role of echocardiography for a comprehensive assessment of cardiac remodeling, and the relationship between indices of cardiac remodeling and cardiovascular events (defined as the composite end point of heart failure hospitalization, heart transplant, or cardiovascular death) in adults with congenitally corrected transposition of great arteries (cc-TGA). Methods: This is a retrospective study of adults with cc-TGA who underwent echocardiogram (2003–2020). Offline image analysis was performed in all patients. Chamber (atrial and ventricular) function and size were assessed by strain imaging and 2-dimensional echocardiography. Results: Of 233 patients with cc-TGA (40±15 years), 123 (55%) had at least one cardiac procedure before baseline echocardiogram. Of 233 patients, 76% and 61% had left atrial dysfunction and systemic right ventricular dysfunction, respectively; while 43% and 11% had right atrial dysfunction and left ventricular dysfunction, respectively. During a median follow-up of 8.9 years, 114 (49%) underwent additional cardiac procedures, and 66 (28%) had cardiovascular events. Left atrial reservoir strain, right ventricular global longitudinal strain, right atrial reservoir strain, left ventricular systolic pressure, and left ventricular global longitudinal strain were independently associated with cardiovascular events. Conclusions: In addition to the clinical importance of right ventricular systolic dysfunction in cc-TGA that is already well described, the current study demonstrated, for the first time, that biatrial dysfunction was common and was associated with clinical outcomes. Since there are currently no effective therapies for atrial and ventricular dysfunction in patients with cc-TGA, there is a need for research to identify novel strategies to prevent atrial and ventricular dysfunction in this population.
Radiation-Induced Heart Disease
Quintero-Martinez, Juan Andres , Cordova-Madera, Sandra N., Villarraga, Hector R., Quintero-Martinez, Juan A , Cordova-Madera, Sandra N., Villarraga, Hector R.

Mayo Clinic

Journal of Clinical Medicine | December 28, 2021 | Volume: 11 | Issue: 1 | Pages: 146

10.3390/jcm11010146 | PMID 35011887 Get It

Cancer incidence and survivorship have had a rising tendency over the last two decades due to better treatment modalities. One of these is radiation therapy (RT), which is used in 20–55% of cancer patients, and its basic principle consists of inhibiting proliferation or inducing apoptosis of cancer cells. Classically, photon beam RT has been the mainstay therapy for these patients, but, in the last decade, proton beam has been introduced as a new option. This newer method focuses more on the tumor and affects less of the surrounding normal tissue, i.e., the heart. Radiation to the heart is a common complication of RT, especially in patients with lymphoma, breast, lung, and esophageal cancer. The pathophysiology is due to changes in the microvascular and macrovascular milieu that can promote accelerated atherosclerosis and/or induce fibrosis of the myocardium, pericardium, and valves. These complications occur days, weeks, or years after RT and the risk factors associated are high radiation doses (>30 Gy), concomitant chemotherapy (primarily anthracyclines), age, history of heart disease, and the presence of cardiovascular risk factors. The understanding of these mechanisms and risk factors by physicians can lead to a tailored assessment and monitorization of these patients with the objective of early detection or prevention of radiation-induced heart disease. Echocardiography is a noninvasive method which provides a comprehensive evaluation of the pericardium, valves, myocardium, and coronaries, making it the first imaging tool in most cases; however, other modalities, such as computed tomography, nuclear medicine, or cardiac magnetic resonance, can provide additional value.
Lymphocytopenia predicts shortened survival in myelodysplastic syndrome with ring sideroblasts (MDS‐RS) but not in MDS/MPN‐RS‐T
Mangaonkar, Abhishek A. , Farrukh, Faiqa, Reichard, Kaaren K. , Gangat, Naseema , Al‐Kali, Aref , Begna, Kebede H. , Pardanani, Animesh , Patnaik, Mrinal M. , Tefferi, Ayalew , Gangat, Naseema , Begna, Kebede , Pardanani, Animesh , Patnaik, Mrinal , Tefferi, Ayalew , Ketterling, Rhett P.

Mayo Clinic

American Journal of Hematology | December 28, 2021 | Volume: 97 | Issue: 3 | Pages: No page available

10.1002/ajh.26448 | PMID 34961962 Get It

Pediatric data from the All of Us research program: demonstration of pediatric obesity over time
Giangreco, Nicholas , Lina, Sulieman, Qian, Jun , Kouame, Aymone, Subbian, Vignesh , Boerwinkle, Eric , Cicek, Mine , Clark, Cheryl R. , Cohen, Elizabeth, Loperena-Cortes, Roxana, Mayo, Kelsey , Mockrin, Stephen, Ohno‐Machado, Lucila , Schully, Sheri D. , Ramirez, Andrea H. , Giangreco, Nicholas P , Subbian, Vignesh , Qian, Jun, Cohen, Elizabeth, Gebo, Kelly A , Tatonetti, Nicholas P.

Mayo Clinic

JAMIA Open | December 28, 2021 | Volume: 4 | Issue: 4 | Pages: No page available

10.1093/jamiaopen/ooab112 | PMID 35155998 Get It

Abstract Objective To describe and demonstrate use of pediatric data collected by the All of Us Research Program. Materials and Methods All of Us participant physical measurements and electronic health record (EHR) data were analyzed including investigation of trends in childhood obesity and correlation with adult body mass index (BMI). Results We identified 19 729 participants with legacy pediatric EHR data including diagnoses, prescriptions, visits, procedures, and measurements gathered since 1980. We found an increase in pediatric obesity diagnosis over time that correlates with BMI measurements recorded in participants’ adult EHRs and those physical measurements taken at enrollment in the research program. Discussion We highlight the availability of retrospective pediatric EHR data for nearly 20 000 All of Us participants. These data are relevant to current issues such as the rise in pediatric obesity. Conclusion All of Us contains a rich resource of retrospective pediatric EHR data to accelerate pediatric research studies.
Development and validation of a novel patient‐reported outcome measure in people with episodic migraine and chronic migraine: The Activity Impairment in Migraine Diary
Gandhi, Pranav , Stokes, Jonathan , Cala, Mary Lynn , Evans, Christopher J. , Knoble, Naomi B., Gelhorn, Heather L. , Revicki, Dennis A. , Viswanathan, Hema N., Dodick, David W. , Dodick, David W , Lipton, Richard B. , Evans, Christopher J.

Mayo Clinic

Headache: The Journal of Head and Face Pain | December 28, 2021 | Volume: 62 | Issue: 1 | Pages: 89-105

10.1111/head.14229 | PMID 34962305 Get It

Abstract Objective To evaluate the content validity and psychometric properties of the Activity Impairment in Migraine Diary (AIM‐D). Background Measuring treatment effects on migraine impairment requires a psychometrically sound patient‐reported outcome (PRO) measure developed consistent with U.S. Food and Drug Administration guidance. Methods The AIM‐D was created from concepts that emerged during qualitative interviews with five clinicians experienced in treating migraine and concept elicitation (CE) interviews with 40 adults with episodic migraine (EM) or chronic migraine (CM). The initial version was refined based on three waves of cognitive interviews with 38 adults with EM or CM and input from a panel of clinical and measurement experts. The AIM‐D was psychometrically evaluated using data from 316 adults with EM or CM who participated in a 13‐week prospective observational study. Study participants completed PRO assessments including the AIM‐D and a daily headache diary. Exploratory and confirmatory factor analysis were used to determine the factor structure. The reliability, validity, and responsiveness of the AIM‐D were assessed. Additional PRO measures including the Patient Global Impression – Severity (PGI‐S), Migraine Specific Quality of Life Questionnaire, Version 2.1 Role Function‐Restrictive domain, and Headache Impact Test were used for psychometric evaluation of the AIM‐D. Results Based on CE interviews with adults with migraine and input from an expert panel, activity impairment was identified as the target in the preliminary conceptual framework, which had two domains: performance of daily activities (PDAs) and physical impairment (PI). Revision of the draft AIM‐D through multiple rounds of cognitive interviews and expert panel meetings resulted in a content valid 11‐item version. Exploratory factor analysis supported both one‐ and two‐domain structures for the AIM‐D, which were further supported by confirmatory factor analysis (factor loadings all >0.90). The AIM‐D domains (PDA and PI) and total score showed high internal consistency reliability (Cronbach's alpha 0.95–0.97), acceptable test–retest reliability for weekly average scores (intraclass correlation coefficient >0.60 for participants with no change in PGI‐S between baseline and week 2), and good convergent and known‐groups validity. There was evidence of responsiveness based on changes in PGI‐S score and monthly migraine days. Conclusion The AIM‐D is a content valid and psychometrically sound measure designed to evaluate activity impairment and is suitable for use in clinical trials of preventive treatments for EM or CM.
Association of COVID‐19 antigenicity with the development of antineutrophilic cytoplasmic antibody vasculitis
Felzer, Jamie , Fogwe, Delvise T. , Michet, Clement J. , Baqir, Misbah , Kubbara, Aahd , Felzer, Jamie R, Kubbara, Aahd F , Samrah, Shaher M. , Specks, Ulrich

Mayo Clinic

Respirology Case Reports | December 28, 2021 | Volume: 10 | Issue: 1 | Pages: No page available

10.1002/rcr2.894 | PMID 34992785 Get It

AbstractInflammatory processes, such as an infection or drug reaction, can cause antineutrophil cytoplasmic autoantibody (ANCA)‐associated vasculitis (AAV). Although quite rare, AAV may occur with SARS‐coronavirus disease 2019 (COVID‐19) antigenic exposure, either from infection or immunization. We present two cases of AAV: one that developed after COVID‐19 infection presenting as diffuse alveolar haemorrhage and another that developed shortly after vaccination, presenting as granulomatous pulmonary nodules. Both patients improved with supportive care and immunosuppressive therapies. This adverse event appears to be a very rare complication of COVID‐19 infection or vaccination. Early diagnosis of AAV is important because immunosuppressive therapy may improve patient outcomes.
Colonic Diverticulosis and Non-Alcoholic Fatty Liver Disease: Is There a Connection?
Pantić, Ivana , Lugonja, Sofija , Rajović, Nina , Dumic, Igor , Milovanovic, Tamara, Alempijević, Tamara , Alempijevic, Tamara , Dumic, Igor , Rajovic, Nina

Mayo Clinic

Medicina | December 28, 2021 | Volume: 58 | Issue: 1 | Pages: 38

10.3390/medicina58010038 | PMID 35056346 Get It

Background and Objectives: The development and severity of colonic diverticulosis and non-alcoholic fatty liver disease (NAFLD) has been associated with several components of metabolic syndrome (MetS). Therefore, this study aimed to evaluate a possible connection between NAFLD, colonic diverticulosis, and MetS. Materials and Methods: This retrospective study included patients diagnosed with diverticulosis between January 2017 and December 2019. Data regarding the patient demographics, Diverticular Inflammation and Complication Assessment (DICA) score and category, disease localization, hepatic steatosis, blood pressure, comprehensive metabolic panel, need for colonic surgery, and co-morbidities were collected from medical records. Results: A total of 407 patients with a median age of 68 years (range, 34–89 years) were included (male: 53.81%). The majority was diagnosed with left-sided diverticulosis (n = 367, 90.17%) and an uncomplicated disease course (DICA category 1, n = 347, 85.3%). Concomitant hepatic steatosis was detected in 47.42% (n = 193) of patients. The systolic blood pressure, triglycerides, total cholesterol, C-reactive protein (CRP), and fasting glucose were higher in the NAFLD group (p < 0.001, p < 0.001, p < 0.001, p < 0.001, and p < 0.001, respectively). A higher prevalence of hypertension (HTA), type 2 diabetes mellitus (T2DM), and hypothyroidism was noted in the same group of patients (p < 0.001, p < 0.001, and p = 0.008, respectively). High-density lipoprotein cholesterol was lower in patients with more severe forms of diverticulosis (DICA category 2 and 3), while CRP levels were significantly higher (p = 0.006 and p = 0.015, respectively). HTA and NAFLD were more common in patients with more severe forms of colonic diverticulosis (p = 0.016 and p = 0.025, respectively). Using a multivariate logistic regression, the DICA score, CRP, total cholesterol, HTA, and hypothyroidism were identified as discriminating factors for the presence of hepatic steatosis. Conclusion: Components of metabolic dysregulation were prominent in patients diagnosed with colonic diverticulosis and concomitant hepatic steatosis. HTA, T2DM, and hypothyroidism were more frequently observed in this group. Hepatic steatosis was more commonly detected in more severe forms of colonic diverticulosis.
Protocols for Generating Surfaces and Measuring 3D Organelle Morphology Using Amira
Garza-López, Edgar , Vue, Zer , Katti, Prasanna , Neikirk, Kit , Biete, Michelle , Lam, Jacob , Beasley, Heather K. , Marshall, Andrea G. , Rodman, Taylor, Christensen, Trace , Salisbury, Jeffrey L., Vang, Larry , Mungai, Margaret , AshShareef, Salma, Murray, Sandra , Shao, Jianqiang, Streeter, Jennifer , Pereira, Renata O. , Hinton, Antentor , Pereira, Renata O , Hinton, Antentor , Katti, Prasanna , Beasley, Heather K , Murray, Sandra A , Lam, Jacob , Marshall, Andrea G , Glancy, Brian , Abel, E. Dale

Mayo Clinic

Cells | December 28, 2021 | Volume: 11 | Issue: 1 | Pages: 65

10.3390/cells11010065 | PMID 35011629 Get It

High-resolution 3D images of organelles are of paramount importance in cellular biology. Although light microscopy and transmission electron microscopy (TEM) have provided the standard for imaging cellular structures, they cannot provide 3D images. However, recent technological advances such as serial block-face scanning electron microscopy (SBF-SEM) and focused ion beam scanning electron microscopy (FIB-SEM) provide the tools to create 3D images for the ultrastructural analysis of organelles. Here, we describe a standardized protocol using the visualization software, Amira, to quantify organelle morphologies in 3D, thereby providing accurate and reproducible measurements of these cellular substructures. We demonstrate applications of SBF-SEM and Amira to quantify mitochondria and endoplasmic reticulum (ER) structures.
Comparative Analysis of Predictive Biomarkers for PD-1/PD-L1 Inhibitors in Cancers: Developments and Challenges
Yang, Fang , Wang, Jacqueline , Liu, Baorui , Molina, Julian R. , Wang, Jacqueline F , Wang, Yucai

Mayo Clinic

Cancers | December 28, 2021 | Volume: 14 | Issue: 1 | Pages: 109

10.3390/cancers14010109 | PMID 35008273 Get It

Immune checkpoint inhibitors (ICIs) targeting programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) have dramatically changed the landscape of cancer therapy. Both remarkable and durable responses have been observed in patients with melanoma, non-small-cell lung cancer (NSCLC), and other malignancies. However, the PD-1/PD-L1 blockade has demonstrated meaningful clinical responses and benefits in only a subset of patients. In addition, several severe and life-threatening adverse events were observed in these patients. Therefore, the identification of predictive biomarkers is urgently needed to select patients who are more likely to benefit from ICI therapy. PD-L1 expression level is the most commonly used biomarker in clinical practice for PD-1/PD-L1 inhibitors. However, negative PD-L1 expression cannot reliably exclude a response to a PD-1/PD-L1 blockade. Other factors, such as tumor microenvironment and other tumor genomic signatures, appear to impact the response to ICIs. In this review, we examine emerging data for novel biomarkers that may have a predictive value for optimizing the benefit from anti-PD-1/PD-L1 immunotherapy.